6 results
The objective is to study the effect of beta-agonist and beta-antagonist treatment on human bone remodeling.
To establish the drug drug interaction of paracetamol with propranolol and the effect of this interaction on the pharmacokinetic profile and metabolites of paracetamol.
To study nocturnal FFA rhythm with or without *-blockers in insulin resistant subjects and healthy controls.
To evaluate whether acute stress induced by a byngy jump alters the status of the innate immune system
To anwer the question: Is the elevation of energy expenditure and mitochondrial uncoupling smaller in obese than in lean subjects after mild cold exposure and what is the role of the sympathetic nervous system?
The primary objective is to determine the clinical response of propranolol monotherapy in patients with angiosarcoma. The secondary endpoint is to assess the pathologic response of propranolol monotherapy in patients with angiosarcoma.